Adam Meyers, DO
Pain Medicine · Ocean, NJNPI 1972554426
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,439 of the $4,797 with a category attached, or 71.7%. 20 manufacturers reported payments, led by Nevro Corp. at 37.5% of the total. Reporting peaked in 2024 at $1,608 and has fallen 74.1% since, to $417 in 2025.
Across 133 payments — averaging $36.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Pacira Pharmaceuticals Incorporated$924
- Medtronic$698
- Globus Medical$273
- Collegium Pharmaceutical, Inc.$214
- MML US, Inc.$195
- plus $693 from 14 others
What the payments were for
- Travel & lodging$1,35828%
- Food & beverage$3,43972%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 48 | $1,801 |
| Pacira Pharmaceuticals Incorporated | 6 | $924 |
| Medtronic(2 entities) | 15 | $698 |
| Globus Medical | 10 | $273 |
| Collegium Pharmaceutical, Inc. | 15 | $214 |
| MML US, Inc. | 6 | $195 |
| Vertos Medical, Inc. | 1 | $157 |
| Boston Scientific | 8 | $151 |
| Si-bone, Inc. | 8 | $79 |
| Zimmer Biomet | 1 | $64 |
| Scilex Pharmaceuticals Inc. | 3 | $42 |
| Johnson & Johnson | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Biodelivery Sciences International, Inc. | 2 | $25 |
| Biotronik NRO, Inc. | 1 | $22 |
| Vertiflex, Inc. | 1 | $19 |
| Abbott | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Pfizer | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$842
- Senza Spinal Cord Stimulation System$515
- mild Device Kit$157
- VANTA ADAPTIVESTIM$120
- Senza$102
How this compares
$4,797 in reported general payments places this provider in the 75th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 34 | $38,021 |
| OxycontinOxycodone Hcl | 45 | $30,393 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 176 | $28,259 |
| Xtampza ErOxycodone Myristate | 20 | $7,571 |
| Hysingla ErHydrocodone Bitartrate | 13 | $6,749 |
| Lidocaine | 72 | $6,082 |
| Gabapentin | 489 | $5,122 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 257 | $5,038 |
| MovantikNaloxegol Oxalate | 12 | $4,904 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 245 | $4,771 |
| Buprenorphine | 17 | $3,770 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 203 | $2,966 |
| Tramadol Hcl | 419 | $2,902 |
| Buprenorphine Hcl | 88 | $2,821 |
| Oxycodone Hcl | 188 | $2,295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er | $214 | $45,59254 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 256 pain medicine providers in New Jersey.
Other pain medicine in Ocean
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
- Dipan PatelClifton$50K
- Matthew LesneskiMount Laurel$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.